BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2780
-0.0070 (-2.46%)
At close: Apr 2, 2026, 4:00 PM EDT
0.2744
-0.0036 (-1.29%)
After-hours: Apr 2, 2026, 7:58 PM EDT
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $7.08 million as of April 2, 2026. Its market cap has decreased by -37.87% in one year.
Market Cap
7.08M
Enterprise Value
4.17M
1-Year Change
-37.87%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has increased from $6.50M to $7.08M, an increase of 8.97%. That is a compound annual growth rate of 1.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 7.10M | -31.73% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 7.66M |
| CollPlant Biotechnologies | 7.63M |
| Creative Medical Technology Holdings | 7.59M |
| Aptorum Group | 7.54M |
| PharmaCyte Biotech | 7.41M |
| Processa Pharmaceuticals | 7.37M |
| Can-Fite BioPharma | 6.96M |
| Xenetic Biosciences | 6.90M |